European Medicines Agency Adopts Positive Opinion Recommending Approval Of Xyrem(REG) For The Treatment Of Narcolepsy With Cataplexy In Adult Patients

Sat, 27 Jan 2007 08:00 PM EST

... UCB has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending that the European Commission grants marketing authorisation for Xyrem(REG) (sodium oxybate) in the treatment of narcolepsy with cataplexy in adult patients. [click link for full article] ...